$CAVA

UBS cuts Cava stock price target to $85 on near-term headwinds

UBS reduced its price target for Cava Group (NYSE:CAVA) to $85 from $90, citing near-term headwinds but maintaining a Buy rating. The stock has fallen over 43% in six months. UBS expects Q3 same-store sales near 3%, below consensus, with Q4 trends improving. Cava plans to open 75-77 new units in 2026. The company reported 27% revenue growth and $0.56 EPS over the last year. Other analysts have mixed views on the stock.

Original reporting
Published Oct 22, 2026, 1:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CAVA
Bearish
medium confidence
Mentioned
$CAVA
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CAVABearishLow
01

Why it matters

Analyst target revisions reflect mixed confidence; while earnings beat is positive, concerns over food‑safety headlines and macro pressure dominate sentiment.

02

Market read

Analyst revisions after CAVA's earnings could influence short‑term price action and sector sentiment.

03

What to watch

Potential upside from sustainability initiatives and menu innovation not fully reflected in current targets.

Relevance 5/10Novelty 4/10Timing: post‑earnings today

Background

Cava Group reported a 27% revenue growth year‑over‑year and beat earnings expectations, prompting a wave of analyst updates.

Company-level read

Ticker impact

$CAVABearishMedium confidence
Context

UBS lowered its price target on Cava Group to $85 and several analysts adjusted targets after the company's recent earnings beat.

Expected impact

likely pressure as the market prices in the lower price targets

Evidence & confidence

Multiple analysts reduced targets, indicating concerns about near‑term growth and macro headwinds.

Market effects

restaurant sector may face scrutiny as analysts reassess growth outlooks for fast‑casual chains.

U.S. equity market, particularly consumer discretionary, could see modest ripple effects.

Limited to U.S. markets; no immediate global impact.

Counterpoint

Despite target cuts, CAVA's strong same‑store sales and new‑store pipeline could support upside if macro pressures ease.

Key entities

  • UBS

    Reduced CAVA price target to $85.

  • DA Davidson

    Lowered target to $75 citing Cyclospora impact.

  • Melius

    Upgraded CAVA to Buy with $95 target.

Related articles

$CAVAHigh

CAVA Group Has Lost 37% in 6 Months: Melius Sees 82% Upside

CAVA Group's shares fell 37% over six months, partly due to a Cyclospora outbreak. Melius Research upgraded it to Buy with a $95 target, 82% above the Oct. 7 close, citing strong fundamentals and overreaction to recent issues. Analysts expect EPS growth to resume in 2027. CAVA trades at 78x forward earnings, below its 3-year average.

$CAVAMed

CAVA Unveils Share Repurchase

CAVA Group, Inc. (NYSE: CAVA) announced a share repurchase program, authorized to buy up to $100 million of its common stock. The program, valid until September 17, 2027, may be executed through open market purchases, private transactions, or other means. The company plans to fund repurchases with existing cash and operational cash flows.

$WENMed

WEN, CMG, SBUX, MCD, CAVA Stocks: Seaport Sees One Stock Stand Out Amid Restaurant Traffic Weakness, Valuation Risks

Seaport Research initiated coverage on five restaurant chains, rating Wendy's (WEN), Chipotle (CMG), Starbucks (SBUX), and McDonald's (MCD) 'Neutral', while naming CAVA Group (CAVA) 'Buy'. The firm cited weaker restaurant traffic, rising oil prices, and inflation as pressures on the industry. CAVA was highlighted for its growth potential and lower brand awareness, with a $58 price target.